Summary
This Form 8-K filing from II-VI Incorporated (now Coherent Corp.) on April 1, 2011, primarily announces the appointment of Dr. Howard H. Xia as an independent director to its Board of Directors. Dr. Xia will serve in Class One, with his term expiring in 2012, though he will officially stand for election by shareholders at the November 2011 annual meeting. This appointment is a key governance update, indicating the company's ongoing efforts to strengthen its board composition and expertise.
Key Highlights
- 1II-VI Incorporated appointed Dr. Howard H. Xia as an independent director.
- 2Dr. Xia's appointment is to Class One of the Board, with his current term expiring in 2012.
- 3Dr. Xia will stand for election by shareholders at the Company's next annual meeting in November 2011.
- 4As of the filing date, Dr. Xia is not intended to serve on any Board Committee.
- 5The company issued a press release regarding Dr. Xia's appointment, which is attached as an exhibit.
- 6The filing is made under Item 5.02 of Form 8-K, which covers director and officer changes.
- 7Key executives, Francis J. Kramer (President and CEO) and Craig A. Creaturo (CFO and Treasurer), signed the report.
Frequently Asked Questions
Dr. Howard H. Xia has been appointed as an independent director to the Board of Directors of II-VI Incorporated. While the filing doesn't detail the specific reasons for his appointment, such appointments are typically made to bring in new expertise, perspectives, and to strengthen corporate governance.
Dr. Xia has been appointed to Class One of the Board, with his current term expiring in 2012. He will be subject to shareholder election at the Company's next annual meeting in November 2011.
As of the date of this filing, the Board of Directors does not intend for Dr. Xia to serve on any Board Committee.
This filing is significant as it pertains to changes in the company's Board of Directors, which is a key component of corporate governance. An independent director appointment can signal strategic direction or a focus on enhancing board oversight and expertise.